Cargando…

Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology

Cardio-oncology is a clinical/scientific discipline which aims to prevent and/or treat cardiovascular diseases in cancer patients. Although a large number of cancer treatments are known to cause cardiovascular toxicity, they are still widely used because they are highly effective. Unfortunately, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelgawad, Ibrahim Y., Grant, Marianne K.O., Zordoky, Beshay N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471701/ https://www.ncbi.nlm.nih.gov/pubmed/30875799 http://dx.doi.org/10.3390/nu11030627

Ejemplares similares

CYP1B1 as a therapeutic target in cardio-oncology
por: Carrera, Alexa N., et al.
Publicado: (2020)

Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
por: Albini, Adriana, et al.
Publicado: (2010)

Leveraging Population Genomics to Enhance Preventive Cardio-Oncology
por: Gaziano, Liam, et al.
Publicado: (2022)

Sexual Dimorphism in Doxorubicin-induced Systemic Inflammation: Implications for Hepatic Cytochrome P450 Regulation
por: Grant, Marianne K.O., et al.
Publicado: (2020)

Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology
por: Liang, Zehua, et al.
Publicado: (2022)

The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-Oncology
por: Cheng, Richard K., et al.
Publicado: (2022)

Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field
por: Liu, Victor Y., et al.
Publicado: (2018)

Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
por: Lopez-Mattei, Juan C., et al.
Publicado: (2021)

Bradyarrhythmias in Cardio-Oncology
por: Fonseca, Marta, et al.
Publicado: (2021)

Metformin mitigates SASP secretion and LPS-triggered hyper-inflammation in Doxorubicin-induced senescent endothelial cells
por: Abdelgawad, Ibrahim Y., et al.
Publicado: (2023)

Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome
por: Tilemann, Lisa M., et al.
Publicado: (2018)

Artificial intelligence applications in cardio-oncology: Leveraging high dimensional cardiovascular data
por: Chen, Haidee, et al.
Publicado: (2022)

Cardio-Oncology in Iran
por: Alizadehasl, Azin, et al.
Publicado: (2021)

Cardio-oncology in 2022
por: Dobson, Rebecca
Publicado: (2023)

Lack of sexual dimorphism in a mouse model of isoproterenol-induced cardiac dysfunction
por: Grant, Marianne K. O., et al.
Publicado: (2020)

EA.hy926 Cells and HUVECs Share Similar Senescence Phenotypes but Respond Differently to the Senolytic Drug ABT-263
por: Abdelgawad, Ibrahim Y., et al.
Publicado: (2022)

Hypertension management in cardio-oncology
por: Essa, Hani, et al.
Publicado: (2020)

The Establishment of the Nordic Cardio-Oncology Society
por: Broberg, Agneta Månsson, et al.
Publicado: (2020)

Doxorubicin Paradoxically Ameliorates Tumor-Induced Inflammation in Young Mice
por: Abdelgawad, Ibrahim Y., et al.
Publicado: (2021)

Cardio-toxicity among patients with sarcoma: a cardio-oncology registry
por: Shamai, Sivan, et al.
Publicado: (2020)

Cardio-oncology: Concepts and practice
por: Cubbon, Richard M., et al.
Publicado: (2016)

New avenues in cardio-oncology
por: Sala, Valentina, et al.
Publicado: (2019)

The Role of Biomarkers in Cardio-Oncology
por: Ananthan, Kajaluxy, et al.
Publicado: (2020)

Cardio-Oncology: Stronger Together
por: Kovacs, Richard J., et al.
Publicado: (2019)

Strain Imaging in Cardio-Oncology
por: Liu, Jennifer E., et al.
Publicado: (2020)

Birth and Maturation of Cardio-Oncology
por: Bhatt, Deepak L.
Publicado: (2019)

My Hope for Cardio-Oncology
por: Ky, Bonnie
Publicado: (2022)

Advancing Cardio-Oncology in Asia
por: Ng, Choon Ta, et al.
Publicado: (2022)

Natriuretic Peptides, Cardio-Oncology…
Publicado: (2023)

The Heidelberg cardio-oncology unit (COUNT)—a possible blueprint for improved care of cardio-oncological patients
por: Lehmann, L. H., et al.
Publicado: (2021)

Proceedings From the Global Cardio-Oncology Summit: The Top 10 Priorities to Actualize for CardioOncology
por: Lenihan, Daniel J., et al.
Publicado: (2019)

Editorial: Cardio-oncology and reverse cardio-oncology: the manifold interconnections between heart failure and cancer
por: Ghigo, Alessandra, et al.
Publicado: (2023)

Cardio-Oncology Considerations in Oncologic Treatment Decisions
por: Fadol, Anecita P.
Publicado: (2022)

Considerations of Competing Risks Analysis in Cardio-Oncology Studies: JACC: CardioOncology State-of-the-Art Review
por: Li, Yimei, et al.
Publicado: (2022)

Developing a Clinical Cardio-Oncology Program and the Building Blocks for Success: JACC: CardioOncology How To
por: Fradley, Michael G., et al.
Publicado: (2023)

The cardio-protective diet
por: Sivasankaran, S.
Publicado: (2010)

The Crossroads of Geriatric Cardiology and Cardio-Oncology
por: Nguyen, Kim-Lien, et al.
Publicado: (2015)

Cardio-Oncology: mechanisms of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2018)

Cardio-oncology: need for novel structures
por: Michel, Lars, et al.
Publicado: (2019)

Cardio-oncology: management of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5e8ve7fm0cbdju56jha76vccvq